Citation Impact
Citing Papers
Improvement of comparative model accuracy by free-energy optimization along principal components of natural structural variation
2004 StandoutNobel
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Unified Synthesis of Polycyclic Alkaloids by Complementary Carbonyl Activation**
2021 StandoutNobel
Structure-Based Optimization Strategies for G Protein-Coupled Receptor (GPCR) Allosteric Modulators: A Case Study from Analyses of New Metabotropic Glutamate Receptor 5 (mGlu 5 ) X-ray Structures
2018
Expansive discovery of chemically diverse structured macrocyclic oligoamides
2024 StandoutScienceNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Quantifying biogenic bias in screening libraries
2009
Asymmetric Counteranion‐Directed Catalysis: Concept, Definition, and Applications
2012 StandoutNobel
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
A comprehensive map of molecular drug targets
2016 Standout
Catalytic Three‐Component Ugi Reaction
2008 StandoutNobel
Novel technologies for virtual screening
2004
Synthesis of Small Molecules with High Scaffold Diversity: Exploitation of Metathesis Cascades in Combination with Inter‐ and Intramolecular Diels–Alder Reactions
2010
How many drug targets are there?
2006 Standout
Innovative lead discovery strategies for tropical diseases
2006
STRING v10: protein–protein interaction networks, integrated over the tree of life
2014 Standout
Predicting new molecular targets for known drugs
2009 Nature
Exploring privileged structures: the combinatorial synthesis of cyclic peptides
2002
ChEMBL: a large-scale bioactivity database for drug discovery
2011 Standout
Machine-learning approaches in drug discovery: methods and applications
2014
Network pharmacology: the next paradigm in drug discovery
2008 Standout
New approaches to molecular cancer therapeutics
2006
What is the Likelihood of an Active Compound to Be Promiscuous? Systematic Assessment of Compound Promiscuity on the Basis of PubChem Confirmatory Bioassay Data
2013
The impact of informatics and computational chemistry on synthesis and screening
2001
Multi-target therapeutics: when the whole is greater than the sum of the parts
2006
Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design
2010
Orphan G-protein-coupled receptors and natural ligand discovery
2001
Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
2007
Computational approaches for combinatorial library design and molecular diversity analysis
1997
Binding of Protein Kinase Inhibitors to Synapsin I Inferred from Pair-Wise Binding Site Similarity Measurements
2010
Drug-therapy networks and the prediction of novel drug targets
2008
Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
2016
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
STITCH 4: integration of protein–chemical interactions with user data
2013
Large‐scale prediction of drug–target relationships
2008
Chiral amine/chiral acid as an excellent organocatalytic system for the enantioselective tandem oxa-Michael-aldol reaction
2009
Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure
2007
Modular, Homochiral, Porous Coordination Polymers: Rational Design, Enantioselective Guest Exchange Sorption and Ab Initio Calculations of Host–Guest Interactions
2010
Analysis and optimization of structure-based virtual screening protocols
2003
Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
2009
A global view of drug-therapy interactions
2008
Identification of Odorant-Receptor Interactions by Global Mapping of the Human Odorome
2014
Relating protein pharmacology by ligand chemistry
2007 Standout
Lead discovery using molecular docking
2002
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
2017 Standout
Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets?
2002
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
2009 Standout
Seven-transmembrane receptors
2002 StandoutNobel
Inhibitors of HIV‐1 Protease by Using In Situ Click Chemistry
2006 StandoutNobel
Structure-based development of target-specific compound libraries
2006
Integration of virtual and high-throughput screening
2002
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Diabetic Nephropathy
2012
Fluorine in medicinal chemistry
2007 Standout
Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
2008
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
2011
Multicomponent Reactions with Isocyanides
2000 Standout
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Quantifying the Relationships among Drug Classes
2008
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor
2012 StandoutNobel
Hydrogen Storage in Metal–Organic Frameworks
2011 Standout
A Pipeline To Enhance Ligand Virtual Screening: Integrating Molecular Dynamics and Fingerprints for Ligand and Proteins
2015
Drug—target network
2007
Practical Methodologies for the Synthesis of Indoles
2006 Standout
Correction: Binding of Protein Kinase Inhibitors to Synapsin I Inferred from Pair-Wise Binding Site Similarity Measurements
2010
Ein kurzer, atomökonomischer Zugang zu Tetrahydroxanthenonen
2003
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Recent Developments in Isocyanide Based Multicomponent Reactions in Applied Chemistry
2005 Standout
Multikomponentenreaktionen mit Isocyaniden
2000
Updates on drug–target network; facilitating polypharmacology and data integration by growth of DrugBank database
2015
Recent Advances in Polyoxometalate-Catalyzed Reactions
2015 Standout
Enantioselective Imidation of Sulfides via Enzyme-Catalyzed Intermolecular Nitrogen-Atom Transfer
2014 StandoutNobel
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Finding the sweet spot: the role of nature and nurture in medicinal chemistry
2012
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
Predicting ADME properties and side effects: the BioPrint approach.
2003
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
2000 StandoutScience
Applications of Catalytic Asymmetric Sulfide Oxidations to the Syntheses of Biologically Active Sulfoxides
2005
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints
2017
The Halogen Bond
2016 Standout
Solution- and Solid-Phase Strategies for the Design, Synthesis, and Screening of Libraries Based on Natural Product Templates: A Comprehensive Survey
2001
Complete Field Guide to Asymmetric BINOL-Phosphate Derived Brønsted Acid and Metal Catalysis: History and Classification by Mode of Activation; Brønsted Acidity, Hydrogen Bonding, Ion Pairing, and Metal Phosphates
2014 Standout
Addressing Selective Polypharmacology of Antipsychotic Drugs Targeting the Bioaminergic Receptors through Receptor Dynamic Conformational Ensembles
2013
Kinase-likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology
2008
Privileged Structures: Efficient Chemical “Navigators” toward Unexplored Biologically Relevant Chemical Spaces
2014
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
The scoring bias in reverse docking and the score normalization strategy to improve success rate of target fishing
2017
Enantioselective Synthesis of Sulfoxides: 2000−2009
2010
Drug Target Identification Using Side-Effect Similarity
2008 Science
Alternate Heme Ligation Steers Activity and Selectivity in Engineered Cytochrome P450-Catalyzed Carbene-Transfer Reactions
2018 StandoutNobel
Chemistry: Chemical con artists foil drug discovery
2014 StandoutNature
Solar Synthesis: Prospects in Visible Light Photocatalysis
2014 StandoutScience
Recent Developments in the Synthesis and Utilization of Chiral Sulfoxides
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Conformational Strain of Macrocyclic Peptides in Ligand–Receptor Complexes Based on Advanced Refinement of Bound-State Conformers
2021
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety
2011
Molecular Similarity in Medicinal Chemistry
2013
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
2001
Structure-guided SCHEMA recombination generates diverse chimeric channelrhodopsins
2017 StandoutNobel
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel
Homochiral Metal–Organic Frameworks for Asymmetric Heterogeneous Catalysis
2011 Standout
Works of Jonathan Mason being referenced
Diversity assessment
1999
High-throughput and virtual screening: core lead discovery technologies move towards integration
2000
Analysis and optimization of structure-based virtual screening protocols
2003
Global mapping of pharmacological space
2006
3-D Pharmacophores in Drug Discovery
2001
Synthesis and biological activity of trans-(.+-.)-N-methyl-2-(3-pyridyl)-2-tetrahydrothiopyrancarbothioamide 1-oxide (RP 49356) and analogs: a new class of potassium channel opener
1992
LIBRARY DESIGN AND VIRTUAL SCREENING USING MULTIPLE 4-POINT PHARMACOPHORE FINGERPRINTS
1999
Diversity Profiling and Design Using 3D Pharmacophores: Pharmacophore-Derived Queries (PDQ)
1996
Rational Screening Set Design and Compound Selection: Cascaded Clustering
1998
A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands And Proteins (FLAP): Theory and Application
2007
High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields
2009
High-throughput and virtual screening: core lead discovery technologies move towards integration
2000
New 4-Point Pharmacophore Method for Molecular Similarity and Diversity Applications: Overview of the Method and Applications, Including a Novel Approach to the Design of Combinatorial Libraries Containing Privileged Substructures
1999